SCHEMBL31363233

SCHEMBL31363233

C#CCNc1cnc(C(C)(C)C)cc1OC

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GRM1 Q13255 1/20 0.31
▸ LRRK2 Q5S007 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29812195 0.86 CHRNA7 (0.33) LRRK2
SCHEMBL23144002 0.86 CHRNA7 (0.33) LRRK2
SCHEMBL26419087 0.79 HTR1A (0.35) LRRK2
SCHEMBL29212413 0.74 BRD4 (0.31) GRM1
SCHEMBL31104603 0.74 CYP2B6 (0.32) GRM1
SCHEMBL29812116 0.74 LRRK2 (0.35) GRM1LRRK2
SCHEMBL23144232 0.74 LRRK2 (0.35) GRM1LRRK2
SCHEMBL29212412 0.74 CYP2B6 (0.32) GRM1
SCHEMBL31363478 0.73 HTT (0.39) —
SCHEMBL25033030 0.72 PDCD1 (0.40) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059074-A1 BICYCLIC COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION PMV PHARMACEUTICALS, INC. (US) 2025-03-20 — — WO disclosed
Send feedback